Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

about

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

Item

http://www.wikidata.org/entity/Q37582299

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

@en

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

@nl

type

Item

label

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

@en

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

@nl

prefLabel

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

@en

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

@nl

P1476

Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review.

@en

P2093

Ali Wazir

http://www.w3.org/2001/XMLSchema#string

Clive Wells

http://www.w3.org/2001/XMLSchema#string

Kefah Mokbel

http://www.w3.org/2001/XMLSchema#string

Umar Wazir

http://www.w3.org/2001/XMLSchema#string

P2860

Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.

The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.

Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice?

Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases.

Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.

Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.

Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy.

Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast

Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.

Lobular neoplasia (so-called lobular carcinoma in situ) of the breast.

P304

4863-4868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.5331

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28105193

http://www.w3.org/2001/XMLSchema#string

P932

5228496

http://www.w3.org/2001/XMLSchema#string